MiR-638 acts as a tumor suppressor gene in gastric cancer
Gastric cancer is one of the major causes of cancer mortality. Several microRNAs play a role in the tumor growth and invasion. However, the underlying molecular mechanism remains poorly understood. We detected the miR-638 expression levels in tumor samples and adjacent noncancerous tissues from 68 p...
Gespeichert in:
Veröffentlicht in: | Oncotarget 2017-12, Vol.8 (64), p.108170-108180 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 108180 |
---|---|
container_issue | 64 |
container_start_page | 108170 |
container_title | Oncotarget |
container_volume | 8 |
creator | Shen, Yu Chen, Haiqun Gao, Ling Zhang, Weigang He, Jun Yang, Xiaohua Qin, Lei Xue, Xiaofeng Guo, Zhaoji |
description | Gastric cancer is one of the major causes of cancer mortality. Several microRNAs play a role in the tumor growth and invasion. However, the underlying molecular mechanism remains poorly understood. We detected the miR-638 expression levels in tumor samples and adjacent noncancerous tissues from 68 patients with gastric cancer as well as in the gastric cancer cell line SGC-7901 and SC-M1. The cell cycle was analyzed by flow cytometry, cell proliferation was observed by CCK-8 assay and cell invasion was detected using Transwell assay. MiR-638 was down-regulated in human GC tissues and its expression level was negatively correlated to TNM stage and lymph metastasis. In the cell lines, aberrant expression of miR-638 was related to the cell proliferation, cell cycle and invasion. We also found that SOX2 had a negative correlation with miR-638 in GC tissues, and miR-638 overexpression could decrease SOX2 expression level by directly binding the 3'-UTR of SOX2.
, down-regulating SOX2 by siRNA could counteract the effect of miR-638 inhibitor on GC cells proliferation and invasion. Our results demonstrate that miR-638 may play a pivotal role in the growth and invasion of GC. |
doi_str_mv | 10.18632/oncotarget.22567 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5746134</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1984257628</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-aacbb072284630196ce2479a273cc7305c68ebaf4695d3d037f7ca6a5818e8ec3</originalsourceid><addsrcrecordid>eNpVUE1Lw0AQXUSxpfYHeJEcvaRmd7NfF0GKX1ARRM_LZjuJkSQbdzeC_97Q1lqHgXkw770ZHkLnOFtgySm5cp110fgK4oIQxsURmmKVq5QwRo8P8ATNQ_jIxmK5kESdoglRRHFCyRSpp_ol5VQmxsaQmLGTOLTOJ2Hoew8hjLCCDpK6SyoToq9tYk1nwZ-hk9I0Aea7OUNvd7evy4d09Xz_uLxZpZYqFVNjbFFkghCZc5phxS2QXChDBLVW0IxZLqEwZc4VW9N1RkUprOGGSSxBgqUzdL317YeihbWFLnrT6N7XrfHf2pla_9909buu3JdmIueY5qPB5c7Au88BQtRtHSw0jenADUFjJXPCBCdypOIt1XoXgodyfwZnepO6_ktdb1IfNReH_-0VvxnTH6CHgDU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1984257628</pqid></control><display><type>article</type><title>MiR-638 acts as a tumor suppressor gene in gastric cancer</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free E- Journals</source><creator>Shen, Yu ; Chen, Haiqun ; Gao, Ling ; Zhang, Weigang ; He, Jun ; Yang, Xiaohua ; Qin, Lei ; Xue, Xiaofeng ; Guo, Zhaoji</creator><creatorcontrib>Shen, Yu ; Chen, Haiqun ; Gao, Ling ; Zhang, Weigang ; He, Jun ; Yang, Xiaohua ; Qin, Lei ; Xue, Xiaofeng ; Guo, Zhaoji</creatorcontrib><description>Gastric cancer is one of the major causes of cancer mortality. Several microRNAs play a role in the tumor growth and invasion. However, the underlying molecular mechanism remains poorly understood. We detected the miR-638 expression levels in tumor samples and adjacent noncancerous tissues from 68 patients with gastric cancer as well as in the gastric cancer cell line SGC-7901 and SC-M1. The cell cycle was analyzed by flow cytometry, cell proliferation was observed by CCK-8 assay and cell invasion was detected using Transwell assay. MiR-638 was down-regulated in human GC tissues and its expression level was negatively correlated to TNM stage and lymph metastasis. In the cell lines, aberrant expression of miR-638 was related to the cell proliferation, cell cycle and invasion. We also found that SOX2 had a negative correlation with miR-638 in GC tissues, and miR-638 overexpression could decrease SOX2 expression level by directly binding the 3'-UTR of SOX2.
, down-regulating SOX2 by siRNA could counteract the effect of miR-638 inhibitor on GC cells proliferation and invasion. Our results demonstrate that miR-638 may play a pivotal role in the growth and invasion of GC.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.22567</identifier><identifier>PMID: 29296232</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Research Paper</subject><ispartof>Oncotarget, 2017-12, Vol.8 (64), p.108170-108180</ispartof><rights>Copyright: © 2017 Shen et al. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-aacbb072284630196ce2479a273cc7305c68ebaf4695d3d037f7ca6a5818e8ec3</citedby><cites>FETCH-LOGICAL-c399t-aacbb072284630196ce2479a273cc7305c68ebaf4695d3d037f7ca6a5818e8ec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746134/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746134/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,27907,27908,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29296232$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shen, Yu</creatorcontrib><creatorcontrib>Chen, Haiqun</creatorcontrib><creatorcontrib>Gao, Ling</creatorcontrib><creatorcontrib>Zhang, Weigang</creatorcontrib><creatorcontrib>He, Jun</creatorcontrib><creatorcontrib>Yang, Xiaohua</creatorcontrib><creatorcontrib>Qin, Lei</creatorcontrib><creatorcontrib>Xue, Xiaofeng</creatorcontrib><creatorcontrib>Guo, Zhaoji</creatorcontrib><title>MiR-638 acts as a tumor suppressor gene in gastric cancer</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>Gastric cancer is one of the major causes of cancer mortality. Several microRNAs play a role in the tumor growth and invasion. However, the underlying molecular mechanism remains poorly understood. We detected the miR-638 expression levels in tumor samples and adjacent noncancerous tissues from 68 patients with gastric cancer as well as in the gastric cancer cell line SGC-7901 and SC-M1. The cell cycle was analyzed by flow cytometry, cell proliferation was observed by CCK-8 assay and cell invasion was detected using Transwell assay. MiR-638 was down-regulated in human GC tissues and its expression level was negatively correlated to TNM stage and lymph metastasis. In the cell lines, aberrant expression of miR-638 was related to the cell proliferation, cell cycle and invasion. We also found that SOX2 had a negative correlation with miR-638 in GC tissues, and miR-638 overexpression could decrease SOX2 expression level by directly binding the 3'-UTR of SOX2.
, down-regulating SOX2 by siRNA could counteract the effect of miR-638 inhibitor on GC cells proliferation and invasion. Our results demonstrate that miR-638 may play a pivotal role in the growth and invasion of GC.</description><subject>Research Paper</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVUE1Lw0AQXUSxpfYHeJEcvaRmd7NfF0GKX1ARRM_LZjuJkSQbdzeC_97Q1lqHgXkw770ZHkLnOFtgySm5cp110fgK4oIQxsURmmKVq5QwRo8P8ATNQ_jIxmK5kESdoglRRHFCyRSpp_ol5VQmxsaQmLGTOLTOJ2Hoew8hjLCCDpK6SyoToq9tYk1nwZ-hk9I0Aea7OUNvd7evy4d09Xz_uLxZpZYqFVNjbFFkghCZc5phxS2QXChDBLVW0IxZLqEwZc4VW9N1RkUprOGGSSxBgqUzdL317YeihbWFLnrT6N7XrfHf2pla_9909buu3JdmIueY5qPB5c7Au88BQtRtHSw0jenADUFjJXPCBCdypOIt1XoXgodyfwZnepO6_ktdb1IfNReH_-0VvxnTH6CHgDU</recordid><startdate>20171208</startdate><enddate>20171208</enddate><creator>Shen, Yu</creator><creator>Chen, Haiqun</creator><creator>Gao, Ling</creator><creator>Zhang, Weigang</creator><creator>He, Jun</creator><creator>Yang, Xiaohua</creator><creator>Qin, Lei</creator><creator>Xue, Xiaofeng</creator><creator>Guo, Zhaoji</creator><general>Impact Journals LLC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171208</creationdate><title>MiR-638 acts as a tumor suppressor gene in gastric cancer</title><author>Shen, Yu ; Chen, Haiqun ; Gao, Ling ; Zhang, Weigang ; He, Jun ; Yang, Xiaohua ; Qin, Lei ; Xue, Xiaofeng ; Guo, Zhaoji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-aacbb072284630196ce2479a273cc7305c68ebaf4695d3d037f7ca6a5818e8ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Shen, Yu</creatorcontrib><creatorcontrib>Chen, Haiqun</creatorcontrib><creatorcontrib>Gao, Ling</creatorcontrib><creatorcontrib>Zhang, Weigang</creatorcontrib><creatorcontrib>He, Jun</creatorcontrib><creatorcontrib>Yang, Xiaohua</creatorcontrib><creatorcontrib>Qin, Lei</creatorcontrib><creatorcontrib>Xue, Xiaofeng</creatorcontrib><creatorcontrib>Guo, Zhaoji</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shen, Yu</au><au>Chen, Haiqun</au><au>Gao, Ling</au><au>Zhang, Weigang</au><au>He, Jun</au><au>Yang, Xiaohua</au><au>Qin, Lei</au><au>Xue, Xiaofeng</au><au>Guo, Zhaoji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MiR-638 acts as a tumor suppressor gene in gastric cancer</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2017-12-08</date><risdate>2017</risdate><volume>8</volume><issue>64</issue><spage>108170</spage><epage>108180</epage><pages>108170-108180</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>Gastric cancer is one of the major causes of cancer mortality. Several microRNAs play a role in the tumor growth and invasion. However, the underlying molecular mechanism remains poorly understood. We detected the miR-638 expression levels in tumor samples and adjacent noncancerous tissues from 68 patients with gastric cancer as well as in the gastric cancer cell line SGC-7901 and SC-M1. The cell cycle was analyzed by flow cytometry, cell proliferation was observed by CCK-8 assay and cell invasion was detected using Transwell assay. MiR-638 was down-regulated in human GC tissues and its expression level was negatively correlated to TNM stage and lymph metastasis. In the cell lines, aberrant expression of miR-638 was related to the cell proliferation, cell cycle and invasion. We also found that SOX2 had a negative correlation with miR-638 in GC tissues, and miR-638 overexpression could decrease SOX2 expression level by directly binding the 3'-UTR of SOX2.
, down-regulating SOX2 by siRNA could counteract the effect of miR-638 inhibitor on GC cells proliferation and invasion. Our results demonstrate that miR-638 may play a pivotal role in the growth and invasion of GC.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>29296232</pmid><doi>10.18632/oncotarget.22567</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1949-2553 |
ispartof | Oncotarget, 2017-12, Vol.8 (64), p.108170-108180 |
issn | 1949-2553 1949-2553 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5746134 |
source | PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free E- Journals |
subjects | Research Paper |
title | MiR-638 acts as a tumor suppressor gene in gastric cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T04%3A59%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MiR-638%20acts%20as%20a%20tumor%20suppressor%20gene%20in%20gastric%20cancer&rft.jtitle=Oncotarget&rft.au=Shen,%20Yu&rft.date=2017-12-08&rft.volume=8&rft.issue=64&rft.spage=108170&rft.epage=108180&rft.pages=108170-108180&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.22567&rft_dat=%3Cproquest_pubme%3E1984257628%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1984257628&rft_id=info:pmid/29296232&rfr_iscdi=true |